China FDA Issues Warning To Foreign Firms In Wake Of Heparin Safety Issues
Executive Summary
SHANGHAI - In the wake of the U.S. safety scare related to Baxter Healthcare's heparin, China's State FDA has warned foreign pharmaceutical companies to conduct business only with licensed Chinese companies